Name
Ligands
Accession Number
DBCAT001885
Description

Not Available

Drugs
DrugDrug Description
VTP-194204Nrx194204 has been used in trials studying the treatment of Parkinson's Disease and Non-small Cell Lung Cancer.
2,4-thiazolidinedioneThiazolidinedione has been investigated for the treatment of Type 2 Diabetes, Diabetes Mellitus, and DIABETES MELLITUS, TYPE 2.
PD-217014PD-217,014 has been used in trials studying the treatment of Pain and Irritable Bowel Syndrome.
LG-100268LG-100268 is a retinoid X receptor (RXR) selective compound.
KB-141An anticholesteremic agent.
OliceridineA biased opioid agonist indicated for the management of severe acute pain in adult patients. Through preferential activation of G-protein-coupled signalling pathways, oliceridine provides analgesic effect with a comparable or improved safety profile over conventional opioid agonists.
GW-3965GW-3965 is a liver X receptor ligand.
Drugs & Drug Targets
DrugTargetType
LG-100268Retinoic acid receptor RXR-betatarget
KB-141Thyroid hormone receptor betatarget
KB-141Thyroid hormone receptor alphatarget
OliceridineMu-type opioid receptortarget
OliceridineCytochrome P450 3A4enzyme
OliceridineCytochrome P450 2D6enzyme
OliceridineCytochrome P450 2C9enzyme
OliceridineCytochrome P450 2C19enzyme
GW-3965Oxysterols receptor LXR-betatarget